Eris Lifesciences P/E Ratio

Current P/E Ratio
28.77
High Valuation
High - Growth expectations or overvalued

Eris Lifesciences (ERIS) P/E ratio is 28.77 (High), EPS (TTM) ₹45.33, current price ₹1350.80 on NSE vs historical average P/E of 29.67 (44.4th percentile) — High - Growth expectations or overvalued. Analyse ERIS FII DII holdings to track promoter, FII and institutional holdings.

Current Valuation Metrics

P/E Ratio 28.77
Current Price ₹1350.80
EPS (TTM) ₹45.33
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 29.67
Historical Range 19.65 - 42.0
Percentile 44.4%

Sector Context

Sector Average 49.15
Sector Median 29.34
Sector Rank #11 of 193
Sector Percentile 5.7%

Earnings Breakdown (TTM)

TTM EPS ₹44.98
Mar 2026 ₹20.60
Sept 2025 ₹8.82

ERIS P/E Ratio — Valuation Signal & Historical Context

Eris Lifesciences P/E 28.77 vs historical average 29.67, range 19.65–42.0 — signal: Overvalued. Browse Eris Lifesciences financial data for revenue, profit, balance sheet and cash flow data.

  • Stock appears overvalued with PE of 28.77, suggesting caution for new investments
  • Trading at discount to sector average PE of 49.15

Eris Lifesciences P/E Ratio Historical Trend

ERIS annual price-to-earnings ratio — 9 years, EPS and year-end price. Current P/E 28.77 vs historical average 29.67. For live price, revenue and the complete fundamental profile, see ERIS stock price BSE.

ERIS Historical P/E Ratio — EPS, Year-End Price & Valuation

Eris Lifesciences annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 42.0 31.7 ₹1331.30 NSE High
2024 37.4 24.22 ₹905.80 NSE High
2023 23.39 28.41 ₹664.65 NSE Moderate
2022 26.18 29.2 ₹764.35 NSE High
2021 20.34 29.01 ₹590.10 NSE Moderate
2020 19.65 25.26 ₹496.40 NSE Moderate
2019 32.34 21.4 ₹692.15 NSE High
2018 36.85 21.27 ₹783.85 NSE High
2017 28.88 20.76 ₹599.50 NSE High

ERIS vs Healthcare Peers — P/E Ratio Comparison

Eris Lifesciences P/E 28.77 vs Healthcare average 49.15, median 29.34 — range 0.97–869.57.

Sector Average
49.15
Sector Median
29.34
Lowest P/E
0.97
Highest P/E
869.57
Companies
193
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.97 ₹36 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.13 ₹53 Low
Sun Pharma Advanced Rese… SPARC 4.39 ₹7,561 Low
Ind Swift Laboratories INDSWFTLAB 4.61 ₹1,146 Low
Amwill Health Care AMWILL 6.04 ₹65 Low
Mono Pharmacare MONOPHARMA 6.85 ₹20 Low
Medicamen Organics MEDIORG 6.94 ₹28 Low
Brooks Laboratories BROOKS 7.38 ₹166 Low
Shelter Pharma SHELTER 7.4 ₹54 Low